Derivation Web

source_d5d66129c80d4b51

by researka:v2 · 2026-05-24 18:45:56.944605+04:00

# Alpha memo — telomere

**Headline:** The Telomere Length Paradox: Quantifying Trade-offs Between Cardioprotection and Carcinogenesis Across Subgroups
**Alpha score:** 100/100 (internal triage score; not a certainty claim)
**Confidence:** `evidence_backed_signal`
**Memo surface:** `alpha memo`
**Snapshot:** `2026-05-24T14-42-28Z`
**Run:** `telomere-evidence-2026-05-24T14-42-28Z`

## One-sentence thesis

The Telomere Length Paradox: Quantifying Trade-offs Between Cardioprotection and Carcinogenesis Across Subgroups

## Why this is surprising

Telomere length emerges as a dualistic biomarker where elongation simultaneously lowers cardiovascular risk but elevates cancer susceptibility, with the magnitude of these effects critically modulated by genetic variants, measurement precision, and disease-specific contexts like pulmonary fibrosis.

Known / obvious (do not republish): Telomere length shortens with age; Shorter telomeres are generally associated with higher mortality risk; Telomere length is influenced by genetic factors

Real tension: Fact 1 shows genetically determined longer telomere length lowers coronary heart disease risk, while facts 4 and 7 indicate it raises cancer risk, creating a therapeutic dilemma.

## Evidence receipts

- `fact_id=109012` (`A_core`) — Genetically determined longer telomere length was associated with lowered risk of coronary heart disease (CHD; OR = 0.95, 95% CI: 0.92-0.98) DOI `10.1111/acel.13017`
- `fact_id=109013` (`A_core`) — but raised risk of cancer (OR = 1.11, 95% CI: 1.06-1.16) DOI `10.1111/acel.13017`
- `fact_id=3476` (`A_core`) — the association was stronger in lung cancer (n = 3; OR = 1.690; 95% CI, 1.253-2.280) DOI `10.1158/1055-9965.epi-16-0968`
- `fact_id=3477` (`A_core`) — in men (n = 6; OR = 1.302; 95% CI, 1.120-1.514) DOI `10.1158/1055-9965.epi-16-0968`

## What this changes

Treat this as a focused working signal, not a broad topic claim. It moves review attention from a generic Top 5 list to the specific contrast, receipt bundle, and next extraction that could confirm or kill the thesis.

## Limitations

- This is an alpha memo, not a settled review, guideline, or broad consensus claim.
- Interpret the thesis only within the cited receipt bundle and the explicit weakening checks below.
- Confounding by unmeasured genetic or lifestyle factors in observational studies linking telomere length to disease outcomes.
- Small subgroup sample sizes (e.g., lung cancer, n=3 in fact 11) limit statistical power and generalizability.
- Potential publication bias favoring positive associations in telomere-length studies, especially in meta-analyses.

## What would weaken this

- Confounding by unmeasured genetic or lifestyle factors in observational studies linking telomere length to disease outcomes.
- Small subgroup sample sizes (e.g., lung cancer, n=3 in fact 11) limit statistical power and generalizability.
- Potential publication bias favoring positive associations in telomere-length studies, especially in meta-analyses.

## Strongest counter-evidence

- _No A_core/B_context counter-evidence found in this run; treat this as a single-direction signal until a broader receipt expansion finds a real opposing fact._

## Next extraction

- Oxidative stress markers in relation to telomere dynamics across different populations
- Effects of specific viral infections (e.g., HIV, COVID-19) on telomere length in longitudinal cohorts
- Age-stratified analyses of telomere length associations with liver fibrosis or cognitive decline

## Supporting Top cards

- Variant status was significantly associated with transplant-free survival (discovery: age-, sex-, and ancestry-adjusted hazard ratio, 3.73) _(alpha cues: subgroup, translation_context, functional_endpoint)_
- one SD TL decrement-associated hazard ratio of 1.09 (95% CI: 1.06-1.13) _(alpha cues: functional_endpoint)_
- Genetically determined longer telomere length was associated with lowered risk of coronary heart disease (CHD; OR = 0.95, 95% CI: 0.92-0.98) _(alpha cues: translation_context)_
- the association was stronger in lung cancer (n = 3; OR = 1.690; 95% CI, 1.253-2.280) _(alpha cues: subgroup)_
- longer LTL was associated with higher brain volume (β = 0.43, 95%CI: 0.36-0.50%, p = 0.008, N = 1102) _(alpha cues: baseline)_

## Provenance / priority

- **Topic:** `telomere`
- **Author:** Dom Lynch
- **ORCID:** _not configured_
- **Version:** 1.0
- **License:** CC BY-NC 4.0
- **Canonical URL:** _not assigned_
- **Suggested citation:** Dom Lynch. (2026). The Telomere Length Paradox: Quantifying Trade-offs Between Cardioprotection and Carcinogenesis Across Subgroups. ReseaRka Evidence Index. Version 1.0.
- **Run bundle SHA-256:** `ab69949297858287f1eb29c51a9f98baccd34ca3e116719b882bfb0d39e58817`
- **Memo SHA-256:** `cd82be4cdbcd7d0e0656a9dc4e6c84208ead64361fdd1d70e0b93eeaa27ca430`
- **Priority note:** This memo records the first published framing, source bundle, and evidence receipts for this run. Reuse should cite the canonical version.

{
  "article_type": "alpha_memo",
  "domain_slug": "general",
  "researka_object_type": "submission",
  "researka_submission_id": "35c3e404-4cd2-455a-ae85-c55f78b83667",
  "title": "The Telomere Length Paradox: Quantifying Trade-offs Between Cardioprotection and Carcinogenesis Across Subgroups"
}